Key result
Large decreases (<-2.5%) and increases (≥2.5%) in HbA1C were associated with higher all-cause mortality (adjOR 2.376 and 1.340, respectively; p<0.001) compared to minimal changes.
Why the study?
Data regarding prognoses depending on long-term changes in HbA1C among patients after acute myocardial infarction are scarce.
Do HbA1C levels and their changes over time predict long-term mortality in diabetic patients after acute myocardial infarction?
Cohort (n=4,066)
Do HbA1C levels and their changes over time predict long-term mortality in diabetic patients after acute myocardial infarction?
Odds Ratio: 2.376
p-value: p=<0.001
Both absolute HbA1C values and their changes over time exhibit a U-shaped association with long-term mortality in diabetic patients following acute myocardial infarction.
HbA1c extremes and large changes may flag higher post-MI mortality risk in diabetes; hypothesis-generating for target ranges, needing prospective trials.
Frequent fluctuations of hemoglobin A1c (HbA1C) values predict patient outcomes. However, data regarding prognoses depending on the long-term changes in HbA1C among patients after acute myocardial infarction (AMI) are scarce. We evaluated the prognostic significance of HbA1C levels and changes among diabetic patients (n = 4066) after non-fatal AMI. All the results of HbA1C tests up to the 10-year follow-up were obtained. The changes (∆) of HbA1C were calculated in each patient. The time intervals of ∆HbA1C values were classified as rapid (<one year) and slow (≥one year) changes. The outcome was all-cause mortality. The highest mortality rates of 53.8% and 35.5% were found in the HbA1C < 5.5–7% and ∆HbA1C = −2.5–(−2%) categories. A U-shaped association was observed between HbA1C and mortality: adjOR = 1.887 and adjOR = 1.302 for HbA1C < 5.5% and ≥8.0%, respectively, as compared with 5.5–6.5% (p < 0.001). Additionally, ∆HbA1C was associated with the outcome (U-shaped): adjOR = 2.376 and adjOR = 1.340 for the groups of <−2.5% and ≥2.5% ∆HbA1C, respectively, as compared to minimal ∆HbA1C (±0.5%) (p < 0.001). A rapid increase in HbA1C (but not decrease) was associated with a greater risk of mortality. HbA1C values and their changes are significant prognostic markers for long-term mortality among AMI-DM patients. ∆HbA1C and its timing, in addition to absolute HbA1C values, should be monitored.
No takes yet. Share an insight, caveat, or question.
Plakht et al. (2021) conducted a cohort in Diabetes Mellitus after acute myocardial infarction (n=4,066). Changes in Hemoglobin A1C (∆HbA1C) vs. Minimal ∆HbA1C (±0.5%) was evaluated on All-cause mortality (adjOR 2.376, p=<0.001). Large decreases (<-2.5%) and increases (≥2.5%) in HbA1C were associated with higher all-cause mortality (adjOR 2.376 and 1.340, respectively; p<0.001) compared to minimal changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: